Abstract

 Limited evidence describing the clinical utility of 2 types of portable bone imaging devices suggest that they may be comparable to DXA for predicting the incidence of fracture, but the findings are uncertain.
 Incorporating 1 type of portable bone imaging device into a screening and diagnosis management pathway for osteoporosis was more cost-effective in a Finnish context, compared to an osteoporosis management approach that did not include the portable bone imaging device.
 Two guidelines were found that have recommendations about portable bone imaging devices for screening and diagnosing osteoporosis. Both guidelines reported limited evidence on the use of portable bone imaging devices.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
